Literature DB >> 15153426

Molecular signaling of somatostatin receptors.

Hicham Lahlou1, Julie Guillermet, Marylis Hortala, Fabienne Vernejoul, Stéphane Pyronnet, Corinne Bousquet, Christiane Susini.   

Abstract

Somatostatin is a neuropeptide family that is produced by neuroendocrine, inflammatory, and immune cells in response to different stimuli. Somatostatin acts as an endogenous inhibitory regulator of various cellular functions including secretions, motility, and proliferation. Its action is mediated by a family of G-protein-coupled receptors (called sst1-sst5) that are widely distributed in the brain and periphery. The five receptors bind the natural peptides with high affinity, but only sst2, sst5, and sst3 bind the short synthetic analogs used to treat acromegaly and neuroendocrine tumors. This review covers the current knowledge in somatostatin receptor biology and signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153426     DOI: 10.1196/annals.1294.012

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  36 in total

1.  A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release.

Authors:  Giovanni Di Nardo; Salvatore Oliva; Marina Aloi; Federica Ferrari; Simone Frediani; Adriana Marcheggiano; Salvatore Cucchiara
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

2.  VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes.

Authors:  Ruben Papoian; Andreas Scherer; Muriel Saulnier; Frank Staedtler; André Cordier; Francois Legay; Gerard Maurer; Joerg Staeheli; Jacky Vonderscher; Salah-Dine Chibout
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 3.  Selective agonism in somatostatin receptor signaling and regulation.

Authors:  Agnes Schonbrunn
Journal:  Mol Cell Endocrinol       Date:  2007-10-07       Impact factor: 4.102

4.  Successful use of octreotide to treat Ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia.

Authors:  Michael Rothenberg; Reetesh Pai; Kevin Stuart
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

5.  Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.

Authors:  Antonella Maffei; Ann Marie Segal; Juan Carlos Alvarez-Perez; Adolfo Garcia-Ocaña; Paul E Harris
Journal:  Mol Endocrinol       Date:  2015-03-09

6.  Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Hao Pan; Andrea Kabosova; Mathias Montenarh; Khalil Ahmed; John S Penn; Candy K Chan; David R Hinton; Maria B Grant; Alexander V Ljubimov
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Somatostatin receptor subtype 4 modulates L-type calcium channels via Gβγ and PKC signaling in rat retinal ganglion cells.

Authors:  Spring R Farrell; Donald R Rankin; Nicholas C Brecha; Steven Barnes
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

8.  Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus.

Authors:  Chiara Ristori; Maurizio Cammalleri; Davide Martini; Barbara Pavan; Yanqiang Liu; Giovanni Casini; Massimo Dal Monte; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-30       Impact factor: 3.000

9.  Somatostatin and cancer: applying endocrinology to oncology.

Authors:  Adda Grimberg
Journal:  Cancer Biol Ther       Date:  2004-08-23       Impact factor: 4.742

10.  Activation of GIRK channels in substantia gelatinosa neurones of the adult rat spinal cord: a possible involvement of somatostatin.

Authors:  Terumasa Nakatsuka; Tsugumi Fujita; Kazuhide Inoue; Eiichi Kumamoto
Journal:  J Physiol       Date:  2008-03-20       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.